Rectal insertion device
Latest AstraZeneca AB Patents:
- Substituted 6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidines, 5,7-dihydrofuro[3,4-d]pyrimidines, and pyrido[2,3-d]pyrimidines as KCC2 modulators
- Graph construction and visualization of multiplex immunofluorescence images
- Apparatus and method for evaluating physical strength or robustness of solid pharmaceutical dosage forms based on an impact strike test
- Chemical compounds
- Medical injector
Description
FIG. 1 is a perspective view of the rectal insertion device according to the present invention.
FIG. 2 is an end elevation view of the rectal insertion device.
FIG. 3 is an opposite end elevation view of the rectal insertion device; and,
FIG. 4 is a side elevation view of the rectal insertion device.
Claims
The ornamental design for a rectal insertion device, as shown.
Referenced Cited
Patent History
Patent number: D443930
Type: Grant
Filed: Mar 31, 2000
Date of Patent: Jun 19, 2001
Assignee: AstraZeneca AB (Sodertalje)
Inventor: Daniel Nestenborg (Brännö)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: White & Case LLP
Application Number: 29/121,112
Type: Grant
Filed: Mar 31, 2000
Date of Patent: Jun 19, 2001
Assignee: AstraZeneca AB (Sodertalje)
Inventor: Daniel Nestenborg (Brännö)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: White & Case LLP
Application Number: 29/121,112
Classifications
Current U.S. Class:
Body Cavity Insertion (e.g., Tampon Or Suppository Applicator, Etc.) (27) (D24/141);
Conduit Or Nozzle (e.g., Syringe, Cannula, Catheter, Etc.) (8) (D24/112);
Speculum, Dilator Or Retractor (25) (D24/135)
International Classification: 2402;
International Classification: 2402;